Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesus Gil

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Nature|November 15, 2011
Senescence surveillance of pre-malignant hepatocytes limits liver cancer developmentTae-Won Kang, Tetyana Yevsa, Norman Woller, et al.
Journal of Proteome Research|February 16, 2026
High-Throughput Proteomics Sample Preparation Using a 96-Channel Pipettor and Magnetic Pin DeviceGeorgia Roumelioti, Alex Montoya, Gemma L M Fisher, et al.
Oncotarget|August 18, 2015
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancerMeng-Lay Lin, Hetal Patel, Judit Remenyi, et al.
Scientific Reports|December 22, 2025
Navitoclax acts synergistically with irradiation to induce apoptosis in preclinical models of H3K27M-altered diffuse midline gliomaAshley Vardon, Scott Haston, Hiba Hamdi, et al.
Aging|December 20, 2016
Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosisMassimiliano Mellone, Christopher J Hanley, Steve Thirdborough, et al.
Nature|July 17, 2024
Inhibition of IL-11 signalling extends mammalian healthspan and lifespanAnissa A Widjaja, Wei-Wen Lim, Sivakumar Viswanathan, et al.
Cell|August 9, 2024
Guidelines for minimal information on cellular senescence experimentation in vivoMikolaj Ogrodnik, Juan Carlos Acosta, Peter D Adams, et al.
Journal of the National Cancer Institute|April 1, 2021
Therapy-Induced Senescence: Opportunities to Improve Anticancer TherapyPataje G Prasanna, Deborah E Citrin, Jeffrey Hildesheim, et al.
European Urology|November 12, 2020
Advanced Prostate Cancer with ATM Loss: PARP and ATR InhibitorsAntje Neeb, Nicolás Herranz, Sara Arce-Gallego, et al.
Acta Neuropathologica|March 16, 2018
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic targetJohn R Apps, Gabriela Carreno, Jose Mario Gonzalez-Meljem, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Nature|November 15, 2011
Senescence surveillance of pre-malignant hepatocytes limits liver cancer developmentTae-Won Kang, Tetyana Yevsa, Norman Woller, et al.
Journal of Proteome Research|February 16, 2026
High-Throughput Proteomics Sample Preparation Using a 96-Channel Pipettor and Magnetic Pin DeviceGeorgia Roumelioti, Alex Montoya, Gemma L M Fisher, et al.
Oncotarget|August 18, 2015
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancerMeng-Lay Lin, Hetal Patel, Judit Remenyi, et al.
Scientific Reports|December 22, 2025
Navitoclax acts synergistically with irradiation to induce apoptosis in preclinical models of H3K27M-altered diffuse midline gliomaAshley Vardon, Scott Haston, Hiba Hamdi, et al.
Aging|December 20, 2016
Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosisMassimiliano Mellone, Christopher J Hanley, Steve Thirdborough, et al.
Nature|July 17, 2024
Inhibition of IL-11 signalling extends mammalian healthspan and lifespanAnissa A Widjaja, Wei-Wen Lim, Sivakumar Viswanathan, et al.
Cell|August 9, 2024
Guidelines for minimal information on cellular senescence experimentation in vivoMikolaj Ogrodnik, Juan Carlos Acosta, Peter D Adams, et al.
Journal of the National Cancer Institute|April 1, 2021
Therapy-Induced Senescence: Opportunities to Improve Anticancer TherapyPataje G Prasanna, Deborah E Citrin, Jeffrey Hildesheim, et al.
European Urology|November 12, 2020
Advanced Prostate Cancer with ATM Loss: PARP and ATR InhibitorsAntje Neeb, Nicolás Herranz, Sara Arce-Gallego, et al.
Acta Neuropathologica|March 16, 2018
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic targetJohn R Apps, Gabriela Carreno, Jose Mario Gonzalez-Meljem, et al.
Pageof 7